Aromatherapy for Mild Cognitive Impairment and Mild Dementia
Official title: Sensory Enrichment Using Aromatherapy for Neurobehavioral and Psychological Symptoms in Early Dementia (SENSE)
Run by National Cancer Centre, Singapore · NCT07234357 · Data updated 2026-11-12
This study tests whether a diffused essential-oil blend for 6 months can help reduce symptoms for people with MCI or mild dementia and lessen caregiver stress.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 50 Years to 99 Years |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | National Cancer Centre, Singapore Academic / other |
| Locations | 2 sites (Singapore and 1 other locations) |
| Status | Recruiting |
| Started | June 9, 2026 |
| Main results expected | November 2027 |
| Study ends | November 2027 |
| Registry record updated | July 17, 2026 |
| Trial ID | NCT07234357 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults 50+, diagnosed with MCI or mild dementia, and with a willing, capable caregiver who languages match the site.
✕Probably not a fit
Patients who do not tolerate or comply with the aromatherapy regimen or have conditions conflicting with essential oils may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
SENSE is a non-blinded, interventional study enrolling about 200 patient–caregiver pairs from Singapore. Participants are randomized to receive either standard care or an aromatherapy package including a diffuser, a proprietary essential oil blend, and a diary, with guidance to diff use twice daily for at least 5 minutes. Caregivers and patients complete cognitive and behavioral assessments at baseline, 12 weeks, and 24 weeks, and caregivers are monitored for burden and mood. The study aims to gauge long-term adherence and safety of supervised aromatherapy in this population.
Why it matters
Potential benefit: If successful, patients may experience improvements in cognitive or behavioral symptoms and caregivers may experience reduced burden.
How similar studies have gone: Previous aromatherapy studies suggest potential symptom relief, but results are mixed; this trial adds structured caregiver involvement and long-term follow-up.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: For patients: * Aged 50 years old and above. * Confirmed diagnosis of MCI or mild dementia based on clinical records. * Has one identified caregiver aged 21 years and above who is willing to provide written informed consent for his/her own participation; is able to read, understand, and speak the designated language at the study site; either lives with the subject or sees the subject for ≥2 hours/day ≥3 days/week; agrees to accompany the subject to each study visit; and is able to verify daily compliance with study intervention. For caregivers: * Aged 21 years old and above. * Willing and able to provide written informed consent * Identified as the caregiver for recruited patient in this study can read, understand, and speak the designated language at the study site; either lives with the recruited patients or sees the patient for ≥2 hours/day ≥3 days/week. * Agrees to accompany the patient to each study visit; and can verify daily compliance with study intervention. Exclusion Criteria: For patients: * Olfactory impaired/dysfunctional. * Known or suspected hypersensitivity/allergy to essential oils or any components of the formulations. * Has Reactive Airway Disease (e.g, Asthma). * Participant without a caregiver. * Pregnant, breastfeeding, or intending to conceive during study period. For caregivers: * Physically or mentally incapable of providing verbal / written consent * Does not have regular or meaningful contact with the participant (e.g. less than 2 hours/day or less than 3 days/week). * Not able to follow patient to each study visit.
Where it's running
-
National Cancer Centre Singapore
Singapore, Singapore Recruiting -
Sengkang General Hospital
Singapore, Singapore Recruiting
Study contacts
- Principal investigator: Prof Teh Bin Tean, MBBS, PhD — National Cancer Centre, Singapore
- Study coordinator: Prof Teh Bin Tean, MBBS, PhD
- Email: teh.bin.tean@singhealth.com.sg
- Phone: +65 66011324
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Dementia-friendly pharmacies as a mental health resource for older adults
This project tests whether pharmacies with memory-test stations can find early cognitive problems in people 60 and older and connect them to follow-up care and support.
-
Investigating new blood tests for diagnosing memory disorders
This study is testing new blood tests to see if they can help diagnose memory disorders like mild dementia and Alzheimer's better than the current method that uses spinal fluid.
-
Examining early biomarkers for Alzheimer's disease
This study is trying to find early signs of Alzheimer's disease in healthy people aged 50 to 80 to help catch the disease sooner.
-
Improving early diagnosis of dementia in primary care
This study is trying to find better ways to diagnose Alzheimer's and other memory problems early in people visiting their primary care doctors.
-
One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions
A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.
-
Choose Myself (Before) Losing Myself
We’re testing an educational interactive booklet to help people with dementia or memory problems think about future medical decisions and start conversations with family or caregivers.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.